Rivoglitazone
Encyclopedia
Rivoglitazone is a thiazolidinedione
undergoing research for use in the treatment of type 2 diabetes.
It is being developed by Daiichi Sankyo Co.
Thiazolidinedione
The thiazolidinediones , also known as glitazones, are a class of medications used in the treatment of diabetes mellitus type 2. They were introduced in the late 1990s.- Mechanism of action :...
undergoing research for use in the treatment of type 2 diabetes.
It is being developed by Daiichi Sankyo Co.
Daiichi Sankyo Co.
is a global pharmaceutical company and the second largest pharmaceutical company in Japan. It achieved JPY 970 billion in revenue in 2010 and is currently ranked number 17 in world sales. Its headquarter is based in Tokyo. The company also owns the American biotechnology company Plexxikon, the...